Sihuan Pharmaceutical Holdings Analysis

SHPHFDelisted Stock  USD 0.1  0.00  0.00%   
Sihuan Pharmaceutical Holdings is overvalued with Real Value of 0.0754 and Hype Value of 0.1. The main objective of Sihuan Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Sihuan Pharmaceutical Holdings is worth, separate from its market price. There are two main types of Sihuan Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Sihuan Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sihuan Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Sihuan Pink Sheet Analysis Notes

About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sihuan Pharmaceutical had 2:1 split on the 5th of June 2014. Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the Peoples Republic of China. The company was founded in 2001 and is based in Wanchai, Hong Kong. Sihuan Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3896 people.The quote for Sihuan Pharmaceutical Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sihuan Pharmaceutical Holdings contact Weicheng Guo at 852 3628 3911 or learn more at https://www.sihuanpharm.com.

Sihuan Pharmaceutical Investment Alerts

Sihuan Pharmaceutical is not yet fully synchronised with the market data
Sihuan Pharmaceutical is way too risky over 90 days horizon
Sihuan Pharmaceutical has some characteristics of a very speculative penny stock
Sihuan Pharmaceutical appears to be risky and price may revert if volatility continues
Sihuan Pharmaceutical has a very high chance of going through financial distress in the upcoming years
About 55.0% of the company outstanding shares are owned by corporate insiders

Sihuan Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sihuan Pharmaceutical's market, we take the total number of its shares issued and multiply it by Sihuan Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sihuan Profitablity

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Sihuan Pharmaceutical Predictive Daily Indicators

Sihuan Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sihuan Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Sihuan Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sihuan Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sihuan shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sihuan Pharmaceutical. By using and applying Sihuan Pink Sheet analysis, traders can create a robust methodology for identifying Sihuan entry and exit points for their positions.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the Peoples Republic of China. The company was founded in 2001 and is based in Wanchai, Hong Kong. Sihuan Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3896 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Sihuan Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Sihuan Pink Sheet

If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Insider Screener
Find insiders across different sectors to evaluate their impact on performance